Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.57 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | RARB | P10826 | 5/20 | 0.41 |
| ▸ | PLK1 | P53350 | 1/20 | 0.41 |
| ▸ | THRA | P10827 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | ESRRG | P62508 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL154857 | 0.89 | CYP4A11 (0.50) | CYP4A11CYP4F2PPARACA2PLK1 | |
| SCHEMBL25867921 | 0.87 | CYP4A11 (0.59) | CYP4A11CYP4F2PPARACA2HSD17B10 | |
| SCHEMBL3687860 | 0.87 | PLK1 (0.41) | CYP4A11CA2HSD17B10RARBPLK1 | |
| SCHEMBL195630 | 0.86 | RARB (0.57) | HSD17B10RARBPLK1THRATHRB | |
| SCHEMBL9808660 | 0.84 | ESR1 (0.45) | CYP4A11CYP4F2HSD17B10RARBPLK1 | |
| SCHEMBL151548 | 0.83 | THRA (0.59) | RARBTHRATHRB | |
| SCHEMBL6692949 | 0.83 | THRA (0.59) | RARBTHRATHRB | |
| SCHEMBL10712859 | 0.83 | THRA (0.59) | RARBTHRATHRB | |
| SCHEMBL10713905 | 0.83 | THRA (0.59) | RARBTHRATHRB | |
| Monoethanolamine SCHEMBL3973136 | 0.83 | CYP4A11 (0.45) | CYP4A11CYP4F2PPARACA2ESRRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5045573-A | Alkanophenones | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-09-03 | — | — | US | claimed |
| EP-0216884-B1 | PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS | MERCK PATENT GmbH (DE) | 1990-08-08 | — | — | EP | claimed |
| EP-0216884-A1 | PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS. | MERCK PATENT GMBH (DE) | 1987-04-08 | — | — | EP | claimed |
| WO-1986005777-A1 | PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-10-09 | — | — | WO | claimed |
| WO-1986005778-A1 | PHOTO-INITIATORS FOR PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-10-09 | — | — | WO | claimed |
| US-20230231142-A1 | FUNCTIONALIZED CROSS-LINKED POLYMER NETWORKS, METHODS OF MAKING SAME, AND USES THEREOF | CORNELL UNIVERSITY | 2023-07-20 | — | — | US | disclosed |
| CN-107531904-B | Polyimide precursor, and liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element containing the same | 日产化学工业株式会社 | 2020-10-30 | — | — | CN | disclosed |
| EP-2935289-B1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | IGM GROUP B V (NL) | 2019-06-26 | — | — | EP | disclosed |
| EP-3459957-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | IGM Group B.V. (NL) | 2019-03-27 | — | — | EP | disclosed |
| US-10040810-B2 | Derivatives of bisacylphosphinic acid, their preparation and use as photoinitiators | BASF SE (DE) | 2018-08-07 | — | — | US | disclosed |
| US-20160039851-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | IGM GROUP B.V. (NL) | 2016-02-11 | — | — | US | disclosed |
| EP-2935289-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | BASF SE (DE) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014095724-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | BASF SE (DE) | 2014-06-26 | — | — | WO | disclosed |
| EP-1793281-B1 | Toner composition and method | XEROX CORP (US) | 2009-02-18 | — | — | EP | disclosed |
| US-5045573-A | Alkanophenones | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1991-09-03 | — | — | US | disclosed |
| EP-0216884-B1 | PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS | MERCK PATENT GmbH (DE) | 1990-08-08 | — | — | EP | disclosed |
| US-4861916-A | Photoinitiators for photopolymerization of unsaturated systems | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-08-29 | — | — | US | disclosed |
| EP-0216884-A1 | PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS. | MERCK PATENT GMBH (DE) | 1987-04-08 | — | — | EP | disclosed |
| WO-1986005778-A1 | PHOTO-INITIATORS FOR PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-10-09 | — | — | WO | disclosed |
| WO-1986005777-A1 | PHOTO-INITIATOR FOR THE PHOTO-POLYMERIZATION OF UNSATURATED SYSTEMS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1986-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039851-A1 | DERIVATIVES OF BISACYLPHOSPHINIC ACID, THEIR PREPARATION AND USE AS PHOTOINITIATORS | ARSA, ACSL6, RER1 | CYP4A11 3210/4885CYP4F2 1797/4885PPARA 256/4885 |
| US-10040810-B2 | Derivatives of bisacylphosphinic acid, their preparation and use as photoinitiators | ARSA, RER1, ACSL6 | CYP4A11 3370/4885CYP4F2 2192/4885PPARA 528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.